National Immunization Programs Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for National Immunization Programs. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
National Immunization Programs Indian Medical PG Question 1: What is the maximum age limit for children covered under the Integrated Child Development Services (ICDS) scheme?
- A. 6 years (Correct Answer)
- B. 10 years
- C. 4 years
- D. 8 years
National Immunization Programs Explanation: ***6 years***
- The **Integrated Child Development Services (ICDS) scheme** is primarily designed to address the nutritional, health, and developmental needs of children under the age of 6.
- This age limit ensures that critical early childhood development—from infancy through preschool—is supported with interventions like **supplementary nutrition**, **immunization**, health check-ups, and pre-school education.
*10 years*
- This age range would extend coverage beyond the **critical early childhood development period** that ICDS focuses on.
- Programs for children aged 6 to 10 years typically fall under primary education or other health initiatives, not the targeted ICDS framework.
*4 years*
- This is **insufficient** as ICDS is specifically designed to cover the entire **0-6 years age group**, ensuring comprehensive early childhood development support.
- Limiting coverage to 4 years would exclude preschool-aged children (4-6 years) from crucial developmental interventions during a critical growth period.
*8 years*
- An 8-year age limit would also exceed the primary target group for ICDS, which emphasizes **early childhood intervention** up to 6 years.
- Children aged 6 to 8 are usually enrolled in primary school, and their specific needs are often addressed through educational and school-based health programs.
National Immunization Programs Indian Medical PG Question 2: Which vaccine is contraindicated in a 6-month-old infant whose sibling is on chemotherapy for leukemia?
- A. Oral polio vaccine (Correct Answer)
- B. Hepatitis B
- C. Rotavirus vaccine
- D. DPT
National Immunization Programs Explanation: ***Oral polio vaccine***
- The **oral polio vaccine (OPV)** is a live attenuated vaccine containing weakened but live viruses.
- It is **absolutely contraindicated** in individuals with immunocompromised household contacts (like a sibling on **chemotherapy**) due to the risk of **vaccine-associated paralytic poliomyelitis (VAPP)** from shedding of the live vaccine virus.
- The shed virus can be transmitted to and cause disease in immunocompromised contacts.
- This is the primary reason most countries have switched to **inactivated polio vaccine (IPV)**.
*Hepatitis B*
- The **Hepatitis B vaccine** is an inactivated (non-live) recombinant vaccine.
- It poses no risk of transmitting live virus to an immunocompromised individual.
- It is safe to administer to an infant with an immunocompromised household contact.
*Rotavirus vaccine*
- The **Rotavirus vaccine** is also a live attenuated vaccine, and there is a **relative contraindication** when household contacts are severely immunocompromised.
- The vaccine virus can be shed in stool for several days after vaccination.
- However, compared to OPV, the risk of serious disease transmission is considered much lower, and some guidelines allow its use with precautions (strict hand hygiene, avoiding diaper changes by immunocompromised contacts).
- In the context of this question, **OPV has a stronger absolute contraindication** than rotavirus vaccine.
*DPT*
- The **DPT vaccine** (Diphtheria, Pertussis, Tetanus) is an **inactivated vaccine** containing toxoids and killed bacterial components.
- It is safe to administer to an infant with an immunocompromised household contact as there is no risk of shedding live pathogens.
National Immunization Programs Indian Medical PG Question 3: Mission Indradhanush was started in
- A. Jan-05
- B. Jul-10
- C. Dec-14 (Correct Answer)
- D. Mar-16
National Immunization Programs Explanation: ***Dec-14***
- Mission Indradhanush, a flagship immunization program in India, was launched on **December 25, 2014**.
- Its primary aim was to **immunize all children and pregnant women** against preventable diseases.
*Jan-05*
- This date does not correspond to the launch of Mission Indradhanush. Other health initiatives or policies may have been introduced around this time.
- The focus on a comprehensive, nationwide immunization drive as seen in Mission Indradhanush came later.
*Jul-10*
- This date is incorrect for the inception of Mission Indradhanush. There were various health programs ongoing in India during 2010.
- No major national immunization campaign of the scale of Mission Indradhanush began in July 2010.
*Mar-16*
- While significant developments and phases of Mission Indradhanush occurred after its launch, March 2016 was not the initiation date.
- This period might have seen the implementation of subsequent phases or intensified efforts of the mission.
National Immunization Programs Indian Medical PG Question 4: Which of the following is NOT a duty of an ASHA worker?
- A. Administering zero dose of DPT and OPV (Correct Answer)
- B. Assessing the success of national programs under ANM
- C. Primary screening for prevalence of non-communicable diseases
- D. All of the options
National Immunization Programs Explanation: ***Correct: Administering zero dose of DPT and OPV***
- **ASHA workers do NOT administer vaccines** - this is strictly beyond their scope of practice
- According to **NRHM guidelines**, ASHAs are **facilitators and mobilizers** for immunization, not vaccine administrators
- Only **ANMs and trained health workers** are authorized to administer vaccines including DPT and OPV
- ASHAs role is to **identify beneficiaries, create awareness, and escort mothers/children to immunization centers**
- Vaccine administration requires technical training and cold chain management that ASHAs are not equipped for
*Incorrect: Assessing the success of national programs under ANM*
- While this is also not a primary ASHA duty, the question asks for what is NOT a duty
- Program assessment is done at district/state levels through monitoring and evaluation teams
- However, between administering vaccines (strictly prohibited) vs program assessment (not their role but may provide data), vaccine administration is more clearly NOT their duty
*Incorrect: Primary screening for prevalence of non-communicable diseases*
- This **IS a duty** of ASHA workers under **NPCDCS** (National Programme for Prevention and Control of Cancer, Diabetes, CVD and Stroke)
- ASHAs conduct basic screening for hypertension, diabetes, and common cancers using simple tools
- They refer suspected cases to appropriate health facilities for confirmation and management
*Incorrect: All of the options*
- This is incorrect because primary NCD screening IS part of ASHA duties, and administering vaccines is the most clearly defined non-duty among the options
National Immunization Programs Indian Medical PG Question 5: A 9-month-old infant is brought to you for immunization. The infant has previously received the first dose of OPV and DPT. What will you do ?
- A. Give the infant second dose of DPT/OPV (Correct Answer)
- B. Give the infant DT/OPV
- C. Repeat the first dose counting afresh
- D. Give the infant a booster dose of DPT/Polio
National Immunization Programs Explanation: ***Give the infant second dose of DPT/OPV***
- As per the **Expanded Programme on Immunization (EPI)** guidelines, even if there's a delay, one should **continue the vaccination schedule** from where it left off, rather than restarting.
- The 9-month-old is due for the **second dose of DPT and OPV**, as the first dose has already been administered.
*Give the infant DT/OPV*
- **DT (Diphtheria and Tetanus)** vaccine is generally given to older children who have contraindications to the pertussis component of DPT or as part of a different schedule.
- At 9 months, the infant still requires the **pertussis component** for protection against whooping cough.
*Repeat the first dose counting afresh*
- There is **no clinical or immunological basis** for restarting the vaccination schedule (counting afresh) simply because of a delay.
- Antibodies from the first dose are still present and contribute to the immune response upon subsequent doses; hence, previous doses are **considered valid**.
*Give the infant a booster dose of DPT/Polio*
- A **booster dose** is typically given much later in childhood (e.g., at 18 months or 5 years) to enhance and prolong immunity after the primary series is completed.
- The infant first needs to **complete the primary series** of DPT and OPV, which involves a second and third dose.
National Immunization Programs Indian Medical PG Question 6: Brain abscess in immunodeficient person is due to :
- A. Aspergillus
- B. Toxoplasma gondii (Correct Answer)
- C. Cryptococcus
- D. Candida
National Immunization Programs Explanation: ***Toxoplasma gondii***
- **Toxoplasma gondii** is a very common cause of **brain abscesses** (cerebral toxoplasmosis) in individuals with compromised immune systems, especially those with AIDS.
- The parasite is usually latent in many people and reactivates when the immune system weakens.
*Aspergillus*
- While *Aspergillus* can cause central nervous system infections, including brain abscesses, this is usually seen in severely **neutropenic** or transplant patients.
- *Aspergillus* typically invades via **hematogenous spread** from a primary pulmonary infection or directly from sinusitis.
*Cryptococcus*
- *Cryptococcus neoformans* is a significant cause of **meningitis** in immunocompromised patients, particularly those with HIV/AIDS.
- While it can cause **cryptococcomas** (focal lesions), pure abscess formation is less common than with *Toxoplasma*.
*Candida*
- *Candida* species can cause **brain microabscesses** or multifocal lesions, especially in patients with disseminated candidiasis originating from prolonged hospitalization or indwelling catheters.
- However, large, solitary brain abscesses are less typical for *Candida* compared to *Toxoplasma gondii*.
National Immunization Programs Indian Medical PG Question 7: Which of the following methods can be used to detect congenital rubella infection in the fetus?
- A. IgA Antibody in fetal blood
- B. IgM antibody in fetal blood (Correct Answer)
- C. Fetal hemoglobin
- D. T4 cell count
National Immunization Programs Explanation: ***IgM antibody in fetal blood***
- **IgM antibodies** are the first antibodies produced in response to an infection and do not cross the **placental barrier**.
- Their presence in fetal blood indicates that the fetus has mounted its own immune response to an infection, such as **rubella**.
*IgA Antibody in fetal blood*
- **IgA antibodies** are primarily found in mucous secretions and are not routinely used for diagnosing congenital infections in fetal blood.
- While IgA can be produced by the fetus, **IgM** is the more definitive marker for acute fetal infection.
*Fetal hemoglobin*
- **Fetal hemoglobin (HbF)** is a normal component of fetal blood and its presence is not indicative of an infection.
- HbF levels can be used to assess fetal anemia or certain hemoglobinopathies, but not infectious diseases.
*T4 cell count*
- **T4 cell count** (CD4+ T cells) is a measure of immune system function, often used in conditions like HIV.
- It does not directly detect the presence of the rubella virus or antibodies against it.
National Immunization Programs Indian Medical PG Question 8: An 80-year-old woman, a retirement home resident, has multiple bouts of pneumonia caused by Streptococcus pneumoniae. In an attempt to prevent such infections, polyvalent vaccines directed at multiple serotypes of the organism have been administered but have not elicited long-acting immunity. Which of the following is the probable explanation for this phenomenon?
- A. The bacterial capsule binds C3b, facilitating activation of the alternative complement pathway, inducing complement-mediated lysis, and preventing immunization.
- B. The capsular polysaccharides of S. pneumoniae have limited hapten potential.
- C. S. pneumoniae evades host immune response by forming capsular coatings composed of host proteins and recognized as "self" antigens.
- D. Memory T lymphocytes respond poorly to polysaccharide antigens. (Correct Answer)
National Immunization Programs Explanation: ***Correct: Memory T lymphocytes respond poorly to polysaccharide antigens.***
- T cells are activated by **peptide antigens** presented by MHC molecules; they do not recognize **polysaccharide antigens** directly.
- Vaccines composed of purified polysaccharide antigens (like in the polyvalent *S. pneumoniae* vaccine) primarily stimulate a **T-cell-independent B-cell response**, which typically results in a weaker immune response, poor memory, and limited class switching, especially in older individuals.
- This is why **conjugate vaccines** (polysaccharide linked to protein carriers) were developed—they convert the T-independent antigen into a T-dependent one, generating better memory responses.
*Incorrect: S. pneumoniae evades host immune response by forming capsular coatings composed of host proteins and recognized as "self" antigens.*
- The capsule of *S. pneumoniae* is composed of **polysaccharides**, not host proteins.
- It evades the immune system by being poorly immunogenic and preventing phagocytosis, but not by mimicking "self" antigens.
*Incorrect: The bacterial capsule binds C3b, facilitating activation of the alternative complement pathway, inducing complement-mediated lysis, and preventing immunization.*
- The **capsule** of *S. pneumoniae* actually **inhibits C3b binding** and prevents activation of the alternative complement pathway, thereby *resisting* complement-mediated lysis and opsonization.
- This resistance is a mechanism of immune evasion, not prevention of immunization.
*Incorrect: The capsular polysaccharides of S. pneumoniae have limited hapten potential.*
- While polysaccharide antigens can be considered haptens in a sense if they require a carrier protein to become fully immunogenic, the primary issue is their inability to activate T cells.
- The limitation in hapten potential isn't the most direct or impactful explanation for the lack of long-lasting immunity compared to the T-cell dependence of memory responses.
National Immunization Programs Indian Medical PG Question 9: Inactivated microorganisms are used in the manufacture of which of the following vaccines?
- A. Salk vaccine (Correct Answer)
- B. Tetanus toxoid
- C. Sabin's oral vaccine
- D. All of the above
National Immunization Programs Explanation: **Explanation:**
The core concept tested here is the classification of vaccines based on the state of the immunizing agent.
**1. Why Salk Vaccine is Correct:**
The **Salk vaccine (IPV - Inactivated Poliovirus Vaccine)** is a classic example of a **killed/inactivated vaccine**. In these vaccines, the microorganism (in this case, Poliovirus types 1, 2, and 3) is grown in culture and then killed using heat or chemicals (usually formaldehyde). While the virus can no longer replicate, its structural proteins remain intact to trigger an immune response, primarily inducing humoral immunity (IgG).
**2. Why the other options are incorrect:**
* **Tetanus Toxoid:** This is a **toxoid vaccine**, not an inactivated whole microorganism. It is prepared by detoxifying the exotoxin produced by *Clostridium tetani* using formalin. It induces immunity against the toxin rather than the bacteria itself.
* **Sabin’s Oral Vaccine (OPV):** This is a **Live Attenuated Vaccine**. It contains weakened but live viruses that replicate in the gut to induce both mucosal (IgA) and systemic (IgG) immunity.
**High-Yield Clinical Pearls for NEET-PG:**
* **Mnemonic for Killed Vaccines:** "**K**illed **P**olice **R**elieve **A**ll **I**nfluenza **B**y **T**yping" (**K**illed: **P**ertussis, **R**abies, **A**-Hepatitis A, **I**nfluenza, **B**-Hepatitis B [Recombinant], **T**yphoid [injectable]).
* **Salk vs. Sabin:** Salk (IPV) is safer for immunocompromised individuals as there is zero risk of Vaccine-Associated Paralytic Poliomyelitis (VAPP), a rare complication seen with Sabin (OPV).
* **Current Schedule:** Under India’s Universal Immunization Programme (UIP), a combination of bOPV and fractional doses of IPV (fIPV) is used.
National Immunization Programs Indian Medical PG Question 10: Which of the following vaccines is NOT typically given for post-splenectomy infection prophylaxis?
- A. Streptococcus pneumoniae
- B. Haemophilus influenzae
- C. Neisseria meningitidis
- D. Escherichia coli (Correct Answer)
National Immunization Programs Explanation: ### Explanation
The spleen plays a critical role in filtering the blood and contains specialized macrophages and B-cells that are essential for clearing **encapsulated organisms**. Following a splenectomy, patients are at a lifelong increased risk of **Overwhelming Post-Splenectomy Infection (OPSI)**, which is characterized by rapid-onset sepsis with high mortality.
**Why Escherichia coli is the correct answer:**
While *E. coli* can cause sepsis, it is not a primary target for post-splenectomy prophylaxis. The risk in asplenic patients is specifically linked to organisms that require **splenic opsonization** for clearance. There is currently no routine vaccine for *E. coli* used in this clinical context, as it is not one of the "Big Three" encapsulated pathogens that dominate OPSI cases.
**Why the other options are incorrect:**
* **Streptococcus pneumoniae (Option A):** The most common cause of OPSI (responsible for ~50-90% of cases). Vaccination with both PCV13 and PPSV23 is mandatory.
* **Haemophilus influenzae type b (Option B):** A major encapsulated pathogen that causes severe respiratory and systemic infections in asplenic individuals.
* **Neisseria meningitidis (Option C):** Asplenic patients have a significantly higher risk of meningococcemia; therefore, the quadrivalent (MenACWY) and Serogroup B vaccines are indicated.
**NEET-PG High-Yield Pearls:**
* **The "Big Three":** Remember the mnemonic **"SHiN"** (*S. pneumoniae, H. influenzae, N. meningitidis*) for encapsulated organisms requiring vaccination.
* **Timing of Vaccination:**
* **Elective Splenectomy:** Administer vaccines at least **14 days before** surgery.
* **Emergency Splenectomy:** Administer vaccines **14 days after** surgery (to avoid the period of post-surgical "immunological stun").
* **Other Risks:** Asplenic patients are also at increased risk for intraerythrocytic parasites like *Babesia* and *Plasmodium* (Malaria).
More National Immunization Programs Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
